Hydroxocobalamin in Refractory Vasodilatory Shock: More Questions than Answers

J Cardiothorac Vasc Anesth. 2023 Sep;37(9):1773-1775. doi: 10.1053/j.jvca.2023.05.001. Epub 2023 May 6.

Authors

Nicolas Kumar¹, Grace R Rahman², Samuel Falkson¹, Shu Yang Lu¹, Adam Dalia¹

Affiliations

¹ Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
² University of North Carolina Gillings School of Global Public Health, Chapel Hill, NC.

PMID: 37225547
DOI: 10.1053/j.jvca.2023.05.001

No abstract available

Publication types

Editorial
Comment

MeSH terms

Humans
Hydroxocobalamin / adverse effects
Hypotension*
Shock* / drug therapy
Vasoconstrictor Agents / therapeutic use
Vasodilation

Substances

Hydroxocobalamin
Vasoconstrictor Agents